A. Vassias

Most-cited papers

1. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

   E. Briasoulis, G. Aravantinos, G. Kouvatseas, P. Pappas +12 more

   2013BMC Cancer83 citations Open access

   Semantic Scholar

   Save

2. Chemotherapy-induced neutropenia in lung cancer patients: the role of antibiotic prophylaxis.

   V. Kouranos, G. Dimopoulos, A. Vassias, K. Syrigos

   2011Cancer Letters41 citations

   Semantic Scholar

   Save

3. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?

   E. Syrigou, N. Makrilia, A. Vassias, I. Nikolaidis +3 more

   2010Anti-Cancer Drugs21 citations Open access

   Semantic Scholar

   Save

4. Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study

   A. Charpidou, Sophia N Tsagouli, S. Tsimpoukis, A. Vassias +4 more

   2010Anti-Cancer Drugs6 citations

   Semantic Scholar

   Save

5. Anaphylaxis during rapid oral desensitization to rifampicin.

   E. Syrigou, D. Grapsa, E. Nanou, M. Zande +3 more

   2016Journal of Allergy and Clinical Immunology: In Practice5 citations

   Semantic Scholar

   Save

6. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

   E. Briasoulis, G. Aravantinos, G. Kouvatseas, P. Pappas +12 more

   2013BMC Cancer1 citations Open access

   Semantic Scholar

   Save

7. Abstract PS3-09-12: Thrombophilia Screening Prior to Tamoxifen Therapy in Early-Stage Hormone Receptor-Positive Breast Cancer: A Three-Year Retrospective Study

   S. Gkoura, I. Binas, E. Aravantinou-Fatorou, T. Bilidas +15 more

   2026Clinical Cancer Research0 citations

   Semantic Scholar

   Save

8. PO-16 Venous thromboembolism in small cell lung cancer patients: an epidemiological study

   E. Dimakakos, K. Livanios, E. Kainis, A. Vassias +4 more

   20210 citations

   Semantic Scholar

   Save

9. Biological predictors of third-line treatment outcomes in patients with advanced non-small cell lung cancer.

   A. Vassias, D. Vassos, D. Grapsa, P. Bakakos +2 more

   20200 citations

   Semantic Scholar

   Save

10. Pembrolizumab versus nivolumab as second and further line treatment in non-small cell lung cancer; a retrospective single-centre study

    Maria Mitsogianni, D. Vassos, I. Kotteas, V. Patriarcheas +6 more

    20200 citations

    Semantic Scholar

    Save

11. EP1.01-90 The Prognostic Role of Mean Platelet Volume in Patients with Advanced Non-Small Cell Lung Cancer

    K. Cholidou, Nektarios Anagnostopoulos, D. Grapsa, E. Kokkotou +6 more

    2019Journal of Thoracic Oncology0 citations Open access

    Semantic Scholar

    Save

12. Prognostic value of mean platelet volume in non-small cell lung cancer: a real-world, registry-based study

    K. Cholidou, N. Anagnostopoulos, D. Grapsa, I. Gkiozos +6 more

    2019Lung Cancer0 citations

    Semantic Scholar

    Save

13. Effects of Smoking Cessation on lung cancer chemotherapy.

    A. Vassias, I. Gkiozos, K. Thomopoulou, M. Zontanos +5 more

    20170 citations Open access

    Semantic Scholar

    Save

14. Factors affecting smoking cessation in patients with cancer

    E. Kokkotou, A. Charpidou, D. Vassos, Aggeliki Florou +4 more

    20170 citations Open access

    Semantic Scholar

    Save

15. Conference Scene: From the Bench to the Bedside: a report from the 2nd Lung Cancer Network, 2012

    A. Vassias, K. Syrigos

    20120 citations

    Semantic Scholar

    Save

16. Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients

    V. Kouranos, A. Vassias, G. Dimopoulos, K. Syrigos

    2011European Respiratory Journal0 citations

    Semantic Scholar

    Save